Novo Nordisk shares surge on results of new obesity drug trial
Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...
GLP-1 Users Are Spending Way Less on Groceries and Fast Food, According to a New Study
Recent research out of Cornell University showed that GLP-1 users' grocery bills have been reduced by as much as 8.6% — with ...
This Wegovy user spent $5,000 on a new wardrobe after losing 80 pounds - and she's not alone
Tori Allen says she's thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more people are using to treat diabetes or lose weight.
News Nation on MSN17h
Ozempic can help other chronic health conditions: Study
GLP-1 weight loss drugs such as Ozempic are known to promote weight loss, but they have other benefits according to a new ...
Futurism18h
Huge Study Finds Constellation of Health Benefits for Ozempic Beyond Weight Loss
In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...
devdiscourse21h
Breakthrough in Muscle Preservation: BCL6 Protein's Role Unveiled
New research highlights the potential of the protein BCL6 in preserving muscle mass, especially when used with popular weight ...
Doctor reacts to Oprah Winfrey’s comment on ‘thin people’: ‘Obesity rates aren’t rising globally because of willpower'
Dr. Karan Rajan responds to Oprah Winfrey's insights on thin people, highlighting the complex biology behind obesity, beyond just willpower.
Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...